Monoclonal Antibody to Prevent Malaria | NEJM

Plasmodium falciparum causes more than 600,000 malaria deaths annually. Whether the monoclonal antibody L9LS can protect children from P. falciparum infection in a region where the organism is endemic is unclear.

Research findings are summarized in a new Quick Take video.

#pediatrics #infectiousdisease #clinicaltrials #nejm

[MFDElk]

The differences look significant with the p values.

This is great. Cost will be a major issue, compared to traditional malaria prophylaxis, right? We're talking 300mg+ of a biologic that needs to be produced, transported and stored.